Not yet recruiting
Chronic obstructive pulmonary disease
Not yet recruitingBronchodilator Response to Inhaled Indacaterol, Glycopyrronium Bromide, and Their Combination in Adults with Moderate to Severe COPD
Investigational
Bronchodilator Response to Inhaled Indacaterol, Glycopyrronium Bromide, and Their Combination in Adults with Moderate to Severe COPD
Investigational
- Disease:Chronic obstructive pulmonary disease
- Substances:IndacaterolGlycopyrronium Bromide
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Indacaterol
- Sponsor:Aerorx Therapeutics Inc.

